Nasdaq
New logo

Innoblative

A medical device company innovating cancer treatment with intelligent ablation devices.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Chicago, IL, US
  • Currency USD
  • Founded October 2013
  • Employees 10
  • Incorporation Type C-corp
  • Website innoblative.com

Company Summary

Innoblative is innovating the treatment of early-stage breast cancer. We are developing a radiofrequency ablation probe that is used intra-operatively to destroy residual cancer left after removal of a tumor, reducing the need for re-operation and dangerous, lengthy, expensive radiation therapy.

Team

  • Default avatar
    Robert (Bob) Rioux
    Chief Technology Officer

    Bob was previously Director of R&D at Angiodynamics and Boston Scientific and VP of R&D at Bovie. He has more than 24 years of experience developing and commercializing medical devices and capital equipment in the gynecology, orthopedic, oncology, surgical, general surgery, and wound care fields. As CTO, Bob manages the development of the Innoblative technology and associated IP.

  • Tyler 20wanke
    Chief Executive Officer

    Prior to attending Northwestern Feinberg School of Medicine and Kellogg School of Management, Tyler worked for the Department of Neurological Surgery at the University of Wisconsin, Northwestern Department of Orthopedic Surgery. He gained relevant experience at Abbott Ventures and Medtronic.

Advisors

  • 21682059 92a5 4e0b 8642 c8db6b6c1c29
    Assistant Professor of Clinical Surgery (Breast Surgery), Northwestern University Feinberg School of Medicine
    2aa7d2ea d82c 431b 889e 9a51ced35ff9
    Director, Coulter Program, Boston University (Former VP Research and Development for Hologic)
    Default avatar
    David Mahvi, MD
    Chief of the Division of Gastrointestinal and Oncologic Surgery, Northwestern Medicine (Co-inventor and Co-founder of Innoblative)
    Unconfirmed
  • Default avatar
    Alan Sahakian, PhD
    Professor and Chair of Electrical Engineering and Computer Science, Professor of Biomedical Engineering, Northwestern University
    Unconfirmed
    Default avatar
    S. Nahum Goldberg
    Head of Interventional Oncology Unit and Director of the Applied Radiology Research Lab, Hebrew University-Hadassah Medical Center; Director, CT Intervention and Tumor Ablation Therapy, Harvard University-Beth Israel Deaconess Medical Center
    Unconfirmed
    Default avatar
    V. Suzanne Klimberg
    Muriel Balsam Kohn Chair in Breast Surgical Oncology at the University of Arkansas for Medical Sciences (UAMS), Director of Diseases of the Breast Fellowship and Director of the Rockefeller Cancer Institute Breast Cancer Program
    Unconfirmed

Previous Investors

  • Default avatar
    Bob Shaw
    Former CEO of Millex
    Unconfirmed
    Default avatar
    James Kelly, MD
    Medical Director, Advanced Center for Cardiothoracic Surgery, LLC
    Unconfirmed
    Default avatar
    Harry Kraemer
    Executive Partner, Madison Dearborn Partners (Former CEO of Baxter International Inc.)
    Unconfirmed